These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10425272)

  • 21. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
    Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development.
    Charles LG; Xie YC; Restifo NP; Roessler B; Sanda MG
    World J Urol; 2000 Apr; 18(2):136-42. PubMed ID: 10854149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
    Belli F; Testori A; Rivoltini L; Maio M; Andreola G; Sertoli MR; Gallino G; Piris A; Cattelan A; Lazzari I; Carrabba M; Scita G; Santantonio C; Pilla L; Tragni G; Lombardo C; Arienti F; Marchianò A; Queirolo P; Bertolini F; Cova A; Lamaj E; Ascani L; Camerini R; Corsi M; Cascinelli N; Lewis JJ; Srivastava P; Parmiani G
    J Clin Oncol; 2002 Oct; 20(20):4169-80. PubMed ID: 12377960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
    Udono H; Levey DL; Srivastava PK
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3077-81. PubMed ID: 7909157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune activity of heat shock protein gp96 and its application in active immunotherapy for tumor and infectious diseases].
    Xu Y; Wang S; Zhang X; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):261-6. PubMed ID: 22712385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
    Dong L; Zhang X; Ren J; Wu S; Yu T; Hou L; Fu L; Yi S; Yu C
    Cancer Biother Radiopharm; 2013 Jun; 28(5):391-7. PubMed ID: 23701419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
    Udono H; Srivastava PK
    J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of multiple heat shock proteins from a single tumor sample.
    Ménoret A; Bell G
    J Immunol Methods; 2000 Apr; 237(1-2):119-30. PubMed ID: 10725457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat-shock protein-peptide complex-96 for the treatment of cancer.
    Amato RJ
    Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma.
    Guo QY; Yuan M; Peng J; Cui XM; Song G; Sui X; Lu SB
    J Exp Clin Cancer Res; 2011 Feb; 30(1):24. PubMed ID: 21352555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock proteins gp96 as immunogens in cancer patients.
    Parmiani G; De Filippo A; Pilla L; Castelli C; Rivoltini L
    Int J Hyperthermia; 2006 May; 22(3):223-7. PubMed ID: 16754342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
    Ménoret A; Chandawarkar R
    Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSPPC-96: a personalised cancer vaccine.
    Caudill MM; Li Z
    Expert Opin Biol Ther; 2001 May; 1(3):539-47. PubMed ID: 11727524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.
    di Pietro A; Tosti G; Ferrucci PF; Testori A
    Expert Opin Biol Ther; 2011 Oct; 11(10):1395-407. PubMed ID: 21801084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of cancer using heat shock proteins.
    Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR
    Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
    Tamura Y; Peng P; Liu K; Daou M; Srivastava PK
    Science; 1997 Oct; 278(5335):117-20. PubMed ID: 9311915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
    Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
    Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
    Heike M; Weinmann A; Bethke K; Galle PR
    Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.